HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Abstract Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Matsuo, M. Articles by Shiraishi, J. Search for Related Content PubMed PubMed Citation Articles by Matsuo, M. Articles by Shiraishi, J. Social Bookmarking                      What's this?

Detection of Malignant Hepatic Tumors

Comparison of Gadolinium-and Ferumoxide-Enhanced MR Imaging

¹ Department of Radiology, Gifu University School of Medicine, 40 Tsukasamachi, Gifu City, Gifu 500-8705, Japan.
² Department of Radiology, Kyoto University Faculty of Medicine, Sakyo-ku, Kyoto 606-8501, Japan.
³ Department of Radiology, Yamaguchi University School of Medicine, Ube City, Yamaguchi 755-8505, Japan.
⁴ Department of Radiology, Osaka City University Hospital, Abeno-ku, Osaka 545-8586, Japan.

View larger version (132K): [in a new window]   Fig. 1A. —69-year-old man with well-differentiated hepatocellular carcinoma (arrow, A and D) and severe cirrhosis. Gadolinium-enhanced hepatic arterial phase (A), equilibrium phase gradient-recalled echo (TR/TE, 150/1.6) (B), ferumoxide-enhanced respiratory-triggered T2-weighted fast spin-echo (5000/80) (C), and breath-hold T2*-weighted gradient-recalled echo (150/10) (D) axial MR images fail to show tumor in B and C. Note that lesion conspicuity is better in A than in D, because of hepatic nodularity, ferumoxide uptake in tumor, and decreased ferumoxides uptake in liver due to cirrhosis.

View larger version (126K): [in a new window]   Fig. 1B. —69-year-old man with well-differentiated hepatocellular carcinoma (arrow, A and D) and severe cirrhosis. Gadolinium-enhanced hepatic arterial phase (A), equilibrium phase gradient-recalled echo (TR/TE, 150/1.6) (B), ferumoxide-enhanced respiratory-triggered T2-weighted fast spin-echo (5000/80) (C), and breath-hold T2*-weighted gradient-recalled echo (150/10) (D) axial MR images fail to show tumor in B and C. Note that lesion conspicuity is better in A than in D, because of hepatic nodularity, ferumoxide uptake in tumor, and decreased ferumoxides uptake in liver due to cirrhosis.

View larger version (134K): [in a new window]   Fig. 1C. —69-year-old man with well-differentiated hepatocellular carcinoma (arrow, A and D) and severe cirrhosis. Gadolinium-enhanced hepatic arterial phase (A), equilibrium phase gradient-recalled echo (TR/TE, 150/1.6) (B), ferumoxide-enhanced respiratory-triggered T2-weighted fast spin-echo (5000/80) (C), and breath-hold T2*-weighted gradient-recalled echo (150/10) (D) axial MR images fail to show tumor in B and C. Note that lesion conspicuity is better in A than in D, because of hepatic nodularity, ferumoxide uptake in tumor, and decreased ferumoxides uptake in liver due to cirrhosis.

View larger version (131K): [in a new window]   Fig. 1D. —69-year-old man with well-differentiated hepatocellular carcinoma (arrow, A and D) and severe cirrhosis. Gadolinium-enhanced hepatic arterial phase (A), equilibrium phase gradient-recalled echo (TR/TE, 150/1.6) (B), ferumoxide-enhanced respiratory-triggered T2-weighted fast spin-echo (5000/80) (C), and breath-hold T2*-weighted gradient-recalled echo (150/10) (D) axial MR images fail to show tumor in B and C. Note that lesion conspicuity is better in A than in D, because of hepatic nodularity, ferumoxide uptake in tumor, and decreased ferumoxides uptake in liver due to cirrhosis.

View larger version (129K): [in a new window]   Fig. 2A. —75-year-old man with histologically proven liver metastases from colon carcinoma (arrows, A—D). Gadolinium-enhanced hepatic arterial phase (A), portal venous phase gradient-recalled echo (TR/TE, 150/1.6) (B), ferumoxide-enhanced respiratory-triggered T2-weighted fast spin-echo (3529/80) (C), and breath-hold T2*-weighted gradient-recalled echo (150/10) (D) axial MR images reveal that tumors (arrows) show ring enhancement characteristic of liver metastases in A, although lesion conspicuity is comparable with gadolinium-enhanced and ferumoxide-enhanced MR images.

View larger version (133K): [in a new window]   Fig. 2B. —75-year-old man with histologically proven liver metastases from colon carcinoma (arrows, A—D). Gadolinium-enhanced hepatic arterial phase (A), portal venous phase gradient-recalled echo (TR/TE, 150/1.6) (B), ferumoxide-enhanced respiratory-triggered T2-weighted fast spin-echo (3529/80) (C), and breath-hold T2*-weighted gradient-recalled echo (150/10) (D) axial MR images reveal that tumors (arrows) show ring enhancement characteristic of liver metastases in A, although lesion conspicuity is comparable with gadolinium-enhanced and ferumoxide-enhanced MR images.

View larger version (148K): [in a new window]   Fig. 2C. —75-year-old man with histologically proven liver metastases from colon carcinoma (arrows, A—D). Gadolinium-enhanced hepatic arterial phase (A), portal venous phase gradient-recalled echo (TR/TE, 150/1.6) (B), ferumoxide-enhanced respiratory-triggered T2-weighted fast spin-echo (3529/80) (C), and breath-hold T2*-weighted gradient-recalled echo (150/10) (D) axial MR images reveal that tumors (arrows) show ring enhancement characteristic of liver metastases in A, although lesion conspicuity is comparable with gadolinium-enhanced and ferumoxide-enhanced MR images.

View larger version (164K): [in a new window]   Fig. 2D. —75-year-old man with histologically proven liver metastases from colon carcinoma (arrows, A—D). Gadolinium-enhanced hepatic arterial phase (A), portal venous phase gradient-recalled echo (TR/TE, 150/1.6) (B), ferumoxide-enhanced respiratory-triggered T2-weighted fast spin-echo (3529/80) (C), and breath-hold T2*-weighted gradient-recalled echo (150/10) (D) axial MR images reveal that tumors (arrows) show ring enhancement characteristic of liver metastases in A, although lesion conspicuity is comparable with gadolinium-enhanced and ferumoxide-enhanced MR images.

View larger version (47K): [in a new window]   Fig. 3. —Bar chart shows values of area under receiver operating characteristic curve (Az values) that describe performance of three observers and pooled data for gadolinium-enhanced MR imaging (striped bar) and ferumoxide-enhanced MR imaging (black bar) in patients overall. Gadolinium-enhanced MR imaging gave significantly (p < 0.05) better data than did ferumoxide-enhanced MR imaging for all three observers and for pooled data.

View larger version (49K): [in a new window]   Fig. 4. —Bar chart shows values of area under receiver operating characteristic curve (Az values) that describe performance of three observers and pooled data for gadolinium-enhanced MR imaging (striped bar) and ferumoxide-enhanced MR imaging (black bar) in patients with cirrhosis. Gadolinium-enhanced MR imaging gave significantly (p < 0.05) better data than did ferumoxide-enhanced MR images for all three observers and for pooled data.

View larger version (47K): [in a new window]   Fig. 5. —Bar chart shows values of area under receiver operating characteristic curve (Az values) that describe performance of three observers and pooled data for gadolinium-enhanced MR imaging (striped bar) and ferumoxide-enhanced MR imaging (black bar) in patients without cirrhosis. Gadolinium-enhanced MR imaging gave significantly (p < 0.05) better data than did ferumoxide-enhanced MR images for observers 2 and 3 and for pooled data.

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati